Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HH-006 in chronic hepatitis B virus infection (Phase II, multiple dosing)
CTR20260608Phase 2Active
- Sponsor
- Huahui Health
- Start
- May 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of HH-006 in Chronic Hepatitis B (CHB), sponsored by Huahui Health. Started May 2026; status: active.
02
Drugs
HH-006
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20260608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260608.